Idenix Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare
CAMBRIDGE, Mass., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals,
Inc. (Nasdaq:IDIX) announced today that Idenix management will present a
corporate overview at the Oppenheimer 23^rd Annual Healthcare Conference on
Wednesday, December 12^th, 2012 at 2:45 p.m. ET at the Waldorf Astoria, New
The live and archived webcast of the company presentation can be accessed
under "Events & Presentations" in the Idenix Investor Center at
www.idenix.com. Please log in approximately 5-10 minutes before the event to
ensure a timely connection. The archived replay will be available on the
Idenix website for two weeks following the conference.
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development of drugs
for the treatment of human viral diseases. Idenix's current focus is on the
treatment of patients with hepatitis C infection. For further information
about Idenix, please refer to http://www.idenix.com.
CONTACT: Idenix Pharmaceuticals Contact:
Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors)
Press spacebar to pause and continue. Press esc to stop.